Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-26-036580
Filing Date
2026-08-07
Accepted
2026-08-07 16:15:30
Documents
1
Period of Report
2026-07-21

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 3589
  Complete submission text file 0001493152-26-036580.txt   4993
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Issuer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OKYO PHARMA LTD. 14-15 CONDUIT STREET LONDON United Kingdom W1S 2XJ
Business Address
Mantelli Flavio (Reporting) CIK: 0002127572 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41386 | Film No.: 261254203